ALTAMIR : Amplitude Surgicals IPO
Paris, 30 June 2015 – Altamir is pleased to announce the initial public offering at end-June of one of its portfolio companies held through the Apax France VIII fund, Amplitude Surgical, a leading French player in the international market for lower limb prostheses.
Listed on Euronext Paris (ISIN: FR0012789667 / Symbol: AMPLI), Amplitude Surgical raised €50m in order to pursue its international expansion.
Altamir sold part of its holding for €14.1m and holds a 14.2% indirect share in the company's capital post-IPO (excluding exercise of the over-allotment option).
The sale was based on a valuation equivalent to 1.7 times the last valuation recorded at December 31, 2014.
1 September (post-trading) NAV as of 30 June 2015 and first-half results
4 November (post-trading) NAV as of 30 September 2015
Altamir (Euronext Paris-B, ticker: LTA) is a listed private equity company with more than €550m in assets under management. The company was created twenty years ago as a means for any investor to access private equity, one of the best performing asset classes over the long term.
Altamir invests via and with the funds managed or advised by Apax Partners France and Apax Partners LLP, two leading private equity firms in their respective markets.
Altamir provides access to a diversified portfolio of fast-growing companies across Apax's sectors of specialisation: TMT, Retail & Consumer, Healthcare, Business & Financial Services; mid-sized companies in French-speaking European countries and larger companies across Europe, North America and key emerging markets.
Altamir derives certain tax benefits from its status as an SCR (“société de capital risque”). As such, Altamir is exempt from corporate tax and the company's investors may benefit from tax exemptions, subject to specific holding-period and dividend-reinvestment conditions.
For more information: www.altamir.fr
Tel: +33 1 53 65 01 74
Communiqués au titre de l'obligation d'information permanente :
- Activité de l'émetteur (acquisitions, cessions...)
Full and original press release in PDF: